A phase I study to assess the safety and immunogenicity of new TB vaccine candidates FP85A and MVA85A, in healthy adults who have previously been immunized with BCG, using a prime-boost delivery schedule

Trial Profile

A phase I study to assess the safety and immunogenicity of new TB vaccine candidates FP85A and MVA85A, in healthy adults who have previously been immunized with BCG, using a prime-boost delivery schedule

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2012

At a glance

  • Drugs MVA 85A (Primary) ; Tuberculosis vaccine
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 19 Dec 2009 'The Welcome Trust' added as trial sponsor as reported by ISRCTN: Current Controlled Trials.
    • 19 Dec 2009 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top